HIF1A and atopic eczema: To conclude, calycosin may be a potential drug for the treatment of allergic dermatitis by regulating tight junctions via inhibiting the expression of HIF‐1α, and as a consequence, HIF‐1α and TJs might be possible therapy targets for allergic dermatitis.